Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Integral Diagnostics Ltd. ( (AU:IDX) ) just unveiled an announcement.
Integral Diagnostics Ltd has issued 99,221 new fully paid ordinary shares on 22 December 2025 following the exercise or conversion of previously unquoted options or other convertible securities. The move modestly increases the company’s share base and reflects the take-up of equity incentives by holders of these instruments, slightly diluting existing shareholders while converting unquoted rights into listed equity.
The most recent analyst rating on (AU:IDX) stock is a Sell with a A$2.10 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.
More about Integral Diagnostics Ltd.
Average Trading Volume: 979,263
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$898.8M
For a thorough assessment of IDX stock, go to TipRanks’ Stock Analysis page.